AstraZeneca’s Enhertu shows promise for broader breast cancer use, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The drug, developed with Japan’s Daiichi Sankyo, showed an improvement in progression-free survival and overall survival in certain cancer patients regardless of their hormone receptor status., The drug, developed with Japan’s Daiichi Sankyo, showed an improvement in progression-free survival and overall survival in certain cancer patients regardless of their hormone receptor status., , Read More